Epigenetic biomarker development

Epigenomics

Volumn 1, Issue 1, 2009, Pages 99-110

  Bock, Christoph ^a  

^a MAX PLANCK INSTITUTE FOR INFORMATICS   (Germany)

Author keywords

Bioinformatics; Cancer; Complex diseases; DNA methylation epigenome; Genome wide association studies; Molecular diagnostics personalized medicine

Indexed keywords

BIOLOGICAL MARKER;

BIOLOGY; DNA METHYLATION; GENETIC ASSOCIATION; GENETIC EPIGENESIS; HUMAN; METABOLISM; NEOPLASM; PATHOLOGY; PERSONALIZED MEDICINE; REVIEW;

BIOLOGICAL MARKERS; COMPUTATIONAL BIOLOGY; DNA METHYLATION; EPIGENESIS, GENETIC; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INDIVIDUALIZED MEDICINE; NEOPLASMS;

EID: 76349113184     PISSN: 17501911     EISSN: 1750192X     Source Type: Journal    
DOI: 10.2217/epi.09.6     Document Type: Review

References (118)

1. Kouzarides T: Chromatin modifications and their function. Cell 128, 693-705 (2007). (Pubitemid 46273577)
2. Weber M, Schiibeler D: Genomic patterns of DNA methylation: targets and function of an epigenetic mark. Curr, Opin. Cell Biol. 19, 273-280 (2007). (Pubitemid 46899512)
3. Reik W: Stability and flexibility of epigenetic gene regulation in mammalian development. Nature 447, 425-432 (2007). (Pubitemid 46816749)
4. Heijmans BT, Tobi EW, Stein AD et al.: Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc. Natl Acad. Sci. USA 105, 17046-17049 (2008).
5. McGowan PO, Sasaki A, D'Alessio AC et al.: Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat. Neurosci. 12, 342-348 (2009).
6. Fraga M.F., Ballestar E, Paz M F et al.: Epigenetic differences arise during the lifetime of monozygotic twins. Proc. Natl Acad. Sci. USA 102, 10604-10609 (2005). (Pubitemid 41061601)
7. Hirst M, Marra MA: Epigenetics and human disease. Int. J. Biochem. Cell Biol. 41, 136-146 (2009).
8. Feinberg AP: Phenotypic plasticity and the epigenetics of human disease. Nature 447, 433-440 (2007). (Pubitemid 46816750)
9. Bjornsson HT, Fallin MD, Feinberg AP: An integrated epigenetic and genetic approach to common human disease. Trends Genet. 20, 350-358 (2004). (Pubitemid 38943025)
10. Richardson B: Primer: epigenecics of autoimmunity. Nat. Clin. Pract. Rheumatol. 3, 521-527 (2007).
11. Mehler MF: Epigenetics and the nervous system. Ann. Neurol. 64, 602-617 (2008).
12. Petronis A: The origin of schizophrenia: genetic thesis, epigenetic antithesis, and resolving synthesis. Biol. Psychiatry 55, 965-970 (2004). (Pubitemid 38581910)
13. Kalsi G, Prescott CA, Kendler K.S., Riley BP: Unraveling the molecular mechanisms of alcohol dependence. Trends Genet. 25, 49-55 (2009).
14. Esteller M: Epigenetics in cancer. N. Engl. J. Med. 358, 1148-1159 (2008).
15. Feinberg AP, Tycko B: The history of cancer epigenetics. Nat. Rev. Cancer 4, 143-153 (2004). (Pubitemid 38198742)
16. Esteller M: Cancer epigenomics: DNA methylomes and historic-modification maps. Nat. Rev. Genet. 8, 286-298 (2007). (Pubitemid 46439286)
17. Jones PA, Baylin SB: The epigenomics of cancer. Cell 128, 683-692 (2007). (Pubitemid 46273572)
18. Feinberg AP, Ohlsson R, Henikoff S: The epigenetic progenitor origin of human cancer. Nat. Rev. Genet. 7, 21-33 (2006). (Pubitemid 41828945)
19. Berger SL, Kouzarides T, Shiekhattar R., Shilatifard A: An operational definition of epigenetics. Genes Dev. 23, 781-783 (2009).
20. Bird A: Perceptions of epigenetics. Nature 447, 396-398 (2007). (Pubitemid 46816744)
21. Suzuki MM, Bird A: DNA mcthylation landscapes: provocative insights from epigenomics. Nat. Rev. Genet. 9, 465-476 (2008). (Pubitemid 351693975)
22. Kondo Y, Shen L, Cheng AS et al.: Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation. Nat. Genet. 40, 741-750 (2008). (Pubitemid 351748874)
23. He L. Thomson JM, Hemann MT et al.: A microRNA polycistron as a potential human oncogene. Nature 435, 828-833 (2005). (Pubitemid 40839734)
24. Lu J, Getz G, Miska EA et al.: MicroRNA expression profiles classify human cancers. Nature 435, 834-838 (2005). (Pubitemid 40839735)
25. Irizarry RA, Ladd-Acosta C, Wen B et al.: The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat. Genet. 41, 178-186 (2009).
26. Weisenberger DJ, Siegmund KD, Campan M et al.: CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with B & 4. F mutation in colorectal cancer. Nat. Genet. 38, 787-793 (2006). (Pubitemid 43980599)
27. Laird PW: The power and the promise of DNA methylation markers. Nat. Rev. Cancer 3, 253-266 (2003). (Pubitemid 37328861)
28. Glockner SC, Dhir M, Yi JM et al.: Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer. Cancer Res. 69, 4691-4699 (2009).
29. Miiller HM, Oberwalder M, Fiegl H et al.: Methylation changes in faecal DNA: a marker for colorectal cancer screening? Lancet 363, 1283-1285 (2004). (Pubitemid 38496491)
30. Payne SR, Serth J, Schostak M et al.: DNA methylation biomarkers of prostate cancer: Confirmation of candidates and evidence urine is the most sensitive body fluid for non-invasive detection. Prostate 69(12), 1257-1269(2009).
31. Woodson K, O'Reilly KJ, Hanson JC, Nelson D, Walk E.L., TangreaJA: The usefulness of the detection of GSTP1 methylation in urine as a biomarker in the diagnosis of prostate cancer. J. Urol. 179, 508-511; discussion 511-512 (2008).
32. Yu J, Zhu T, Wang Z et al.: A novel set of DNA methylation markers in urine sediments for sensitive/specific detection of bladder cancer. Clin. Cancer. Res. 13, 7296-7304 (2007).
33. Friedrich MG, Weisenberger DJ, Cheng JC et al.: Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients. Clin. Cancer. Res. 10, 7457-7465 (2004). (Pubitemid 39557507)
34. Fiegl H, Gattringer C, Widschwendter A et al.: Methylated DNA collected by tampons - a new tool to detect endometrial cancer. Cancer Epidemiol. Biomarkers Prev. 13, 882-888 (2004). (Pubitemid 38737880)
35. Kahn SL, Ronnett BM, Gravitt P.E., Gustafson KS: Quantitative methylation-specific PCR for the detection of aberrant DNA methylation in liquid-based Pap tests. Cancer 114, 57-64(2008). (Pubitemid 351304613)
36. Olesen LH, Aggerholm A, Andersen BL et al.: Molecular typing of adult acute myeloid leukaemia: significance of translocations, tandem duplications, methylation, and selective gene expression profiling. Br. J. Haematol. 131, 457-467 (2005). (Pubitemid 43899642)
37. Strathdee G, Holyoake TL, Sim A et al.: Inactivation of HOXA genes by hypermethylation in myeloid and lymphoid malignancy is frequent and associated with poor prognosis. Clin. Cancer. Res. 13, 5048-5055 (2007). (Pubitemid 47502069)
38. Widschwendter M, Apostolidou S, Raum E et al.: Epigenotyping in peripheral blood cell DNA and breast cancer risk: a proof of principle study. PLoS ONE 3, E2656 (2008).
39. Korshunova Y, Maloney RK, Lakey N et al.: Massively parallel bisulphite pyrosequencing reveals the molecular complexity of breast cancer-associated cytosine-methylation patterns obtained from tissue and serum DNA. Genome Res. 18, 19-29 (2008).
40. Devos T, Tetzner R, Model F et al.: Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer. Clin. Chem. 55(7), 1337-1346 (2009).
41. Grutzmann R, Molnar B, Pilarsky C et al.: Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay. PLoS ONE 3, e3759 (2008).
42. Lofton-Day C., Model F, Devos T et al.: DNA methylation biomarkers for blood-based colorectal cancer screening. Clin. Chem. 54, 414-423 (2008). (Pubitemid 351302625)
43. Issa JP: CpG island methylator phenotype in cancer. Nat. Rev. Cancer 4, 988-993 (2004).
44. Hegi ME, Diserens AC, Gorlia T et al.: MGMTgene silencing and benefit from temozolomide in glioblastoma. N. Engl. J. Med. 352, 997-1003 (2005). (Pubitemid 40349502)
45. Iafrate AJ, Louis DN: "MGMTfor pt mgmt,": is methylguanine-DNA methyltransferase testing ready for patient management?. J. Mm. Diagn. 10, 308-310 (2008). (Pubitemid 352019115)
46. Mikeska T, Bock C, El-Maarri O et al.: Optimization of quantitative MGMT promoter methylation analysis using pyrosequencing and combined bisulfite restriction analysis. J. Mol. Diagn. 9, 368-381 (2007). (Pubitemid 47305073)
47. Bernstein BE, Meissner A, Lander ES: The mammalian epigenome. Cell 128, 669-681 (2007). (Pubitemid 46273573)
48. Jeddeloh JA. Greally JM. Rando OJ: Reduced-representation methylation mapping. Genome Biol. 9, 231 (2008).
49. Meissner A, Mikkelsen TS, Gu H et al.: Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 454, 766-770 (2008).
50. Down TA, Rakyan VK, Turner DJ et al.: A Bayesian deconvolution strategy for immunoprecipitation-based DNA methylome analysis. Nat. Biotechnol. 26, 779-785 (2008). (Pubitemid 351961453)
51. Irizarry RA, Ladd-Acosta C, Carvalho B et al.: Comprehensive high-throughput arrays for relative methylation (CHARM). Genome Res. 18, 780-790 (2008). (Pubitemid 351645068)
52. Oda M, Glass JL, Thompson RF et al.: High-resolution genome-wide cytosine methylation profiling with simultaneous copy number analysis and optimization for limited cell numbers. Nucleic Acids Res. 37(12), 3829-3839 (2009).
53. Ball MP, Li JB, Gao Y et al.: Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells. Nat. Biotechnol. 27, 361-368 (2009).
54. Deng J, Shoemaker R, Xie B et al.: Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming. Nat. Biotechnol. 27, 353-360 (2009).
55. Eckhardt F, Lewin J, Cortese R et al.: DNA methylation profiling of human chromosomes 6, 20 and 22. Nat. Genet. 38, 1378-1385 (2006). (Pubitemid 44837559)
56. Meng H, Murrelle EL, Li G: Identification of a small optimal subset of CpG sites as biomarkers from high-throughput DNA methylation profiles. BMC Bioinfbrmatics 9, 457 (2008).
57. Tost J, Gut IG: DNA methylation analysis by pyrosequencing. Nat. Protoc. 2, 2265-2275 (2007). (Pubitemid 351575045)
58. Gonzalgo ML, Liang G: Methylation-sensitive single-nucleotide primer extension (Ms-SNuPE) for quantitative measurement of DNA methylation. Nat. Protoc. 2, 1931-1936 (2007). (Pubitemid 47308131)
59. Brena RM, Auer H, Kornacker K., Plass C: Quantification of DNA methylation in electrofluidics chips (Bio-COBRA). Nat. Protoc. 1, 52-58 (2006).
60. Ehrich M, Nelson MR, Stanssens P et al.: Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. Proc. Natl Acad. Sci. USA 102, 15785-15790 (2005). (Pubitemid 41552820)
61. Eads CA, Danenberg KD, Kawakami K et al.: MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res. 28, E32 (2000).
62. Herman JG, Graff JR, Myohanen S, Nelkin B.D., Baylin SB: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl Acad. Sci. USA 93, 9821-9826 (1996). (Pubitemid 26296693)
63. Zhang Y, Rohde C, Tierling S et al.: DNA methylation analysis of chromosome 21 gene promoters at single base pair and single allele resolution. PLoS Genet. 5, E1000438 (2009).
64. Bock C, Walter J, Paulsen M., Lengauer T: Inter-individual variation of DNA methylation and its implications for large-scale epigenome mapping. Nucleic Acids Res. 36, e55 (2008).
65. Bock C, Lengauer T: Computational epigenetics. Bioinfbrmatics 24, 1-10 (2008).
66. Reich M, Liefeld T, Gould J., Lerner J, Tamayo P, Mesirov JP: Gene Pattern 2.0. Nat. Genet. 38, 500-501 (2006).
67. Gentleman RC, Carey VJ, Bates DM et al.: Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 5, R80 (2004).
68. Langmead B, Trapnell C., Pop M, Salzberg SL: Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 10, R25 (2009).
69. Li H, Ruan J, Durbin R: Mapping short DNA sequencing reads and calling variants using mapping quality scores. Genome Res. 18, 1851-1858 (2008).
70. Pelizzola M, Koga Y, Urban AE et al.: MEDME: an experimental and analytical methodology for the estimation of DNA methylation levels based on microarray derived MeDIP-enrichment. Genome Res. 18, 1652-1659 (2008).
71. Bock C, Halachev K, Biich J., Lengauer T: EpiGRAPH: User-friendly software for statistical analysis and prediction of (epi-) genomic data. Genome Biol. 10, R14 (2009).
72. Ji, H, Jiang Ma WH, Johnson DS, Myers RM, Wong WH: An integrated software system for analyzing ChlP-chip and ChlP-seq data. Nat. Biotechnol. 26, 1293-1300 (2008).
73. Blankenberg D, Taylor J, Schenck I et al.: A framework for collaborative analysis of ENCODE data: making large-scale analyses biologist-friendly. Genome Res. 17, 960-964 (2007). (Pubitemid 46919731)
74. Du P, Kibbe WA, Lin SM: Lumi: a pipeline for processing Illumina microarray. Bioinfbrmatics 24, 1547-1548 (2008). (Pubitemid 351911712)
75. Dunning MJ, Smith ML, Ritchie M.E., Tavart S: Beadarray: R classes and methods for Illumina bead-based data. Bioinformatics 23, 2183-2184 (2007). (Pubitemid 47394121)
76. Frank E, Hall M, Trigg L., Holmes G, Witten IH: Data mining in bioinformatics using Weka. Bioinformatics 20, 2479-2481 (2004). (Pubitemid 39429925)
77. Bock C, Walter J, Paulsen M., Lengauer T: CpG island mapping by epigenome prediction. PLoS Comput. Biol. 3, e110 (2007).
78. Bock C, Paulsen M, Tierling S., Mikeska T, Lengauer T, Walter J: CpG island methylation in human lymphocytes is highly correlated with DNA sequence, repeats, and predicted DNA structure. PLoS Genet. 2, e26 (2006).
79. Keshet I, Schlesinger Y, Farkash S et al.: Evidence for an instructive mechanism of de novo methylation in cancer cells. Nat. Genet. 38, 149-153 (2006). (Pubitemid 43177227)
80. Goh L, Murphy SK, Muhkerjee S, Furey TS: Genomic sweeping for hypermethylated genes. Bioinformatics 23, 281-288 (2007). (Pubitemid 46323149)
81. McCabe MT, Lee EK, Vertino PM: A multifactorial signature of DNA sequence and polycomb binding predicts aberrant CpG island methylation. Cancer Res. 69, 282-291 (2009).
82. Rhodes DR, Kalyana-Sundaram S, Mahavisno Vet al.: Oncomine 3.0: genes, pathways, and networks in a collection of 18, 000 cancer gene expression profiles. Neoplasia 9, 166-180 (2007).
83. Lauss M, Visne I, Weinhaeusel A., Vierlinger K, Noehammer C, Kriegner A: MethCancerDB-aberrant DNA methylation in human cancer. Br. J. Cancer 98, 816-817 (2008). (Pubitemid 351272608)
84. Suderman M, Hallett M: Tools for visually exploring biological networks. Bioinformatics 23, 2651-2659 (2007). (Pubitemid 350048327)
85. Tusnady GE, Simon I, Varadi A., Aranyi T: BiSearch: primer-design and search tool for PCR on bisulfite-treated genomes. Nucleic Acids Res. 33, e9 (2005).
86. Bock C, Reither S, Mikeska T., Paulsen M, Walter J, Lengauer T: BiQ Analyzer: visualization and quality control for DNA methylation data from bisulfite sequencing. Bioinfbrmatics 21, 4067-4068 (2005). (Pubitemid 41631851)
87. Kumaki Y, Oda M, Okano M: QUMA: quantification tool for methylation analysis. Nucleic Acids Res. 36, W170-5 (2008).
88. Thompson RF, Suzuki M, Lau K.W., Greally JM: A pipeline for the quantitative analysis of CG dinucleotide methylation using mass spectrometry. Bioinformatics 25(17), 2164-2170 (2009).
89. Tarca AL, Carey VJ, Chen X.W., Romero R., Draghici S: Machine learning and its applications to biology. PLoS Comput. Biol. 3, e116 (2007).
90. Witten IH, Frank E: Data mining: practical machine learning tools and techniques with Java implementations. Morgan Kaufmann, CA, USA, 25, 371 (2000).
91. Jurisica I, Wigle D, Wong B: Cancer informatics in the post genomic era: toward information-based medicine. Springer, Berlin, Germany, 19, 180 (2007)
92. Bibikova M, Fan JB: GoldenGate assay for DNA methylation profiling. MethodsMol. Biol. 507, 149-163 (2009).
93. Bibikova M, Lin Z, Zhou L et al.: High-throughput DNA methylation profiling using universal bead arrays. Genome Res. 16, 383-393 (2006). (Pubitemid 43327509)
94. Ley TJ, Mardis ER, Ding L et al.: DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature 456, 66-72 (2008).
95. Wood LD, Parsons DW, Jones S et al.: The genomic landscapes of human breast and colorectal cancers. Science 318, 1108-1113 (2007). (Pubitemid 350134889)
96. Altshulcr D, Daly MJ, Lander ES: Genetic mapping in human disease. Science 322, 881-888 (2008).
97. Ludwig JA, Weinstein JN: Biomarkers in cancer staging, prognosis and treatment selection. Nat. Rev. Cancer 5, 845-856 (2005). (Pubitemid 41746029)
98. McLendon R, Friedman A, Bigner D: Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455, 1061-1068 (2008).
99. Herman JG, Baylin SB: Gene silencing in cancer in association with promoter hypermethylation. N. Engl. J. Med. 349, 2042-2054 (2003). (Pubitemid 37448928)
100. Jones PA, Baylin SB: The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3, 415-428 (2002). (Pubitemid 34587077)
101. Chan TA. Glockner S. Yi JM et al.: Convergence of mutation and epigenetic alterations identifies common genes in cancer that predict for poor prognosis. PLoS Med. 5, ell4 (2008).
102. Hong C, Moorefield KS Jun P et al.: Epigenome scans and cancer genome sequencing converge on WNK2, a kinase-independent suppressor of cell growth. Proc. Natl Acad. Sci. USA 104, 10974-10979 (2007). (Pubitemid 47175211)
103. Schuebel KE, Chen W, Cope L et al.: Comparing the DNA hypermethylome with gene mutations in human colorectal cancer. PLoS Genet. 3, 1709-1723 (2007). (Pubitemid 47510263)
104. Pepe MS, Etzioni R, Feng Z et al.: Phases of biomarker development for early detection of cancer. J. Natl. Cancer Inst. 93, 1054-1061 (2001). (Pubitemid 32717537)
105. Johannes F, Colot V, Jansen RC: Epigenome dynamics: a quantitative genetics perspective. Nat. Rev. Genet. 9, 883-890 (2008).
106. Butcher LM, Beck S: Future impact of integrated high-throughput methylome analyses on human health and disease. J. Genet. Genomics 55, 391-401 (2008). (Pubitemid 351978309)
107. Foley DL, Craig JM, Morley R et al.: Prospects for epigenetic epidemiology. Am. J. Epidemiol. 169, 389-400 (2009).
108. McCarthy MI, Abecasis GR, Cardon LR et al.: Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat. Rev. Genet. 9, 356-369 (2008). (Pubitemid 351556063)
109. Becker KG, Hosack DA, Dennis G Jr, et al.: PubMatrix: a tool for multiplex literature mining. BMC Bioinformatics 4, 61 (2003).
110. Description of the Illumina Infinium HumanMethylation 27 assay www.illumina.com/pages.ilmn?ID=243
111. Software tool for design and optimization of gene-specific DNA methylation assays http://methmarker.mpi-inf.mpg.de/
112. Case study demonstrating DNA methylation analysis with the Illumina Infinium assay www.illumina.com/downloads/InfMethylation-AppNote.pdf
113. Software tool for bisulfite sequencing primer design www. appliedbiosystems.com/methylprimerexpress
114. Software tool for pyrosequencing assay design www.pyrosequencing.com/ DynPage.aspx?id=7257
115. Software tool for EpiTYPER assay design www.epidesigner.com/
116. R software package for statistical analysis www.r-project.org/
117. SAS/STAT software package for statistical analysis www.sas.com/ technologies/anaIytics/statistics/stat/index.html
118. SPSS PASW software package for statistical analysis www.spss.com/ statistics/